MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 10-23-2025
Medpace Holdings Cash Conversion Cycle 2011-2026 | MEDP
Annual Cash Conversion Cycle Medpace Holdings
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 51.5 | 53.4 | 55 | 55.5 | 62.4 | 52.7 | 56.6 | 46.2 | 53.1 | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 62.4 | 46.2 | 54 |
Quarterly Cash Conversion Cycle Medpace Holdings
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 51.9 | 51.1 | 48.6 | - | 52.4 | 50.1 | 51.6 | - | 52.6 | 52.8 | 53.7 | - | 29.6 | 29.2 | 56.7 | - | 53.7 | 52.7 | 56.3 | - | 63.8 | 71.7 | 62.6 | 61.8 | 65.7 | 66.3 | 65.7 | 63.4 | 67.9 | 71.6 | 60.6 | 67.3 | 68.5 | 71.4 | 69.7 | - | 67.5 | 68.7 | 66.4 | - | 32.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 71.7 | 29.2 | 58.1 |
Cash Conversion Cycle of other stocks in the Diagnostics research industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
50.2 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Burning Rock Biotech Limited
BNR
|
149 | $ 23.41 | 0.47 % | $ 252 M |  China |
|
Akumin
AKU
|
36.1 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Biocept
BIOC
|
78.1 | - | -13.05 % | $ 7.29 M |  USA |
 |
Co-Diagnostics
CODX
|
299 | $ 6.0 | -3.07 % | $ 176 M | USA |
 |
Accelerate Diagnostics
AXDX
|
364 | - | -61.36 % | $ 2.46 M | USA |
 |
Castle Biosciences
CSTL
|
45.9 | $ 39.7 | 0.92 % | $ 1.1 B | USA |
 |
DexCom
DXCM
|
133 | $ 70.68 | 4.87 % | $ 27.3 B | USA |
 |
BioNano Genomics
BNGO
|
225 | $ 1.58 | - | $ 2.01 M | USA |
 |
Chembio Diagnostics
CEMI
|
111 | - | 0.22 % | $ 16.8 M | USA |
 |
Guardant Health
GH
|
49.1 | $ 107.76 | -2.19 % | $ 13.2 B | USA |
 |
Global Cord Blood Corporation
CO
|
184 | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
11 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
142 | - | 0.12 % | $ 80.1 M | China |
 |
PRA Health Sciences, Inc.
PRAH
|
1.21 K | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
76.4 | $ 20.41 | 19.15 % | $ 1.1 B | USA |
 |
Danaher Corporation
DHR
|
83.5 | $ 238.83 | 0.2 % | $ 175 B | USA |
 |
DermTech
DMTK
|
66.7 | - | -11.32 % | $ 2.94 M | USA |
 |
DarioHealth Corp.
DRIO
|
207 | $ 11.97 | -1.56 % | $ 340 M |  Israel |
 |
Anixa Biosciences
ANIX
|
385 | $ 3.19 | -5.62 % | $ 102 K | USA |
 |
Illumina
ILMN
|
142 | $ 145.25 | 2.96 % | $ 23.1 B | USA |
 |
Enzo Biochem
ENZ
|
154 | - | -8.98 % | $ 14.8 K | USA |
 |
IQVIA Holdings
IQV
|
78 | $ 241.11 | -0.55 % | $ 43.7 B | USA |
 |
Exact Sciences Corporation
EXAS
|
130 | $ 102.23 | 0.11 % | $ 18.9 B | USA |
 |
Fulgent Genetics
FLGT
|
42.4 | $ 28.16 | 1.11 % | $ 851 M | USA |
 |
Aspira Women's Health
AWH
|
-38.7 | - | -6.19 % | $ 10.5 M | USA |
 |
Lantheus Holdings
LNTH
|
90.9 | $ 67.28 | -0.41 % | $ 4.66 B | USA |
 |
Charles River Laboratories International
CRL
|
67.7 | $ 219.73 | -0.62 % | $ 11.3 B | USA |
 |
Heska Corporation
HSKA
|
138 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
104 | - | -20.0 % | $ 1.06 M | USA |
 |
Mettler-Toledo International
MTD
|
63.7 | $ 1 486.95 | 0.1 % | $ 31.6 B |  Schweiz |
 |
ENDRA Life Sciences
NDRA
|
-1.24 K | $ 4.51 | -3.01 % | $ 2.42 M | USA |
 |
National Research Corporation
NRC
|
33 | $ 20.3 | 2.94 % | $ 498 M | USA |
 |
Neogen Corporation
NEOG
|
150 | $ 9.33 | -3.01 % | $ 2.02 B | USA |
 |
Natera
NTRA
|
81.5 | $ 233.65 | -0.28 % | $ 23 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
38.6 | $ 175.05 | 0.34 % | $ 19.4 B | USA |
|
Biodesix
BDSX
|
41.7 | $ 8.2 | 50.18 % | $ 1.06 B | USA |
 |
Pacific Biosciences of California
PACB
|
149 | $ 2.04 | 4.9 % | $ 517 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
39.8 | $ 249.91 | -0.75 % | $ 21 B | USA |
 |
ICON Public Limited Company
ICLR
|
62 | $ 180.43 | -0.52 % | $ 14.9 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
108 | $ 722.17 | 1.24 % | $ 59.6 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
89 | $ 29.83 | 0.93 % | $ 20 B |  Niderland |
 |
Agilent Technologies
A
|
111 | $ 147.73 | -0.53 % | $ 44.9 B | USA |
 |
Biomerica
BMRA
|
172 | $ 2.66 | -2.56 % | $ 6.11 M | USA |